Giovany Orozco Leal
Eugenie Johnson
Dr Sedighe Hosseinijebeli
Tomos Robinson
Tara Homer
et al. | Considerations for the cure assumption in a NICE Single Technology Appraisal of nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small cell lung cancer: Evidence Assessment Group perspective | 2024 |
|
Tomos Robinson
Giovany Orozco Leal
Dr Ashleigh Kernohan
Will King
Dr Yemi Oluboyede
et al. | Valuing selected WAItE health states using the Time Trade-Off methodology: findings from an online interviewer-assisted remote survey | 2024 |
|
Giovany Orozco Leal
Nigel Armstrong
Dr Ashleigh Kernohan
Dr Diarmuid Coughlan
Tomos Robinson
et al. | Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal | 2023 |
|
Fiona Beyer
Stephen Rice
Giovany Orozco Leal
Madeleine Still
Hannah O'Keefe
et al. | Clinical and cost effectiveness of endoscopic bipolar radiofrequency ablation for the treatment of malignant biliary obstruction: a systematic review | 2023 |
|
Stephen Rice
Katherine Carr
Pauline Sobiesuo
Dr Hosein Shabaninejad
Giovany Orozco Leal
et al. | Economic evaluations of interventions to prevent and control health-care-associated infections: a systematic review | 2023 |
|
Fiona Beyer
Stephen Rice
Giovany Orozco Leal
Madeleine Still
Hannah O'Keefe
et al. | P-P21 Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by unresectable cancer: systematic review of clinical and cost effectiveness | 2021 |
|
Fiona Beyer
Stephen Rice
Giovany Orozco Leal
Madeleine Still
Hannah O'Keefe
et al. | PTU-35 Endoscopic bipolar radiofrequency ablation for treating malignant biliary obstruction: Systematic review and meta-analysis | 2021 |
|
